Tag

Oncopeptides

Anders Martin-Löf

Oncopeptides signs 40 million EUR loan agreement

October 19, 2020

Oncopeptides has entered into a …

Doctor and patient

Oncopeptides initiates US Expanded Access Program

October 1, 2020

Oncopeptides announces that the open-label …

Oncopeptides completes extended enrollment of Phase 3 study

September 8, 2020

Oncopeptides has announced that the …

Marty Duvall

Oncopeptides’ melflufen granted Priority Review

August 31, 2020

The US Food and Drug …

Research clinical trials

Oncopeptides initiates the first study with melflufen outside multiple myeloma

August 11, 2020

Oncopeptides has announced that the …

Klaas Bakker

Oncopeptides starts the phase 2 PORT study

August 10, 2020

Oncopeptides has announced that the …

Jakob Lindberg

Oncopeptides takes over Kancera facility and submits NDA

June 30, 2020

Oncopeptides has agreed with Kancera …

Klaas Bakker

Positive results from Oncopeptides

June 16, 2020

Oncopeptides has announced that the …

Jakob Lindberg

Oncopeptides completes Phase 3 study enrollment

June 3, 2020

Oncopeptides has announced completion of …

Klaas Bakker

Oncopeptides announces new data

May 18, 2020

Oncopeptides has announced that data …

Jakob Lindberg

Oncopeptides’ provides update on its clinical programs due to the COVID-19 pandemic

March 20, 2020

Oncopeptides has announced measures the …

Klaas Bakker

Promising data from Oncopeptides

December 9, 2019

Oncopeptides has presented updated data …

Oncopeptides’ Chief Medical Officer steps down

August 25, 2019

Johan Harmenberg has reached retirement …

Jakob Lindberg

New data from Oncopeptides

June 4, 2019

Data from the company’s Phase 1/2 …

Jakob Lindberg

Oncopeptides to apply for accelerated approval in the US

May 21, 2019

After discussions with the FDA, …

Jakob Lindberg

Additional patent protection for Oncopeptides

April 10, 2019

The US patent and trademark …

1
2